Posted on January 7, 2021 by komornikea

January Jan. 14 CDER Compliance Conference Jan. 26 Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling Jan. 27 OTC Monograph Reform in the CARES Act: Safety Orders, Webinar Jan. 27 Public Meeting: Interim Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act Jan. 29 Regulatory Perspectives for Development of Drugs […]